North Dakota Governor Signs Cannabis-Infused Edible Products Legislation into Law

Image | adobe.stock/squarelogo

Recently in North Dakota, Governor Kelly Armstrong signed House Bill 1203 (ND HB1203) into law which regulates “the manufacturing and dispensing of cannabis-infused edible products to state-qualified patients,” (1).

The new bill entitles patients the ability to obtain “cannabinoid edible products”. According to the new bill, these products are determined to be “soft or hard lozenges in a geometric square shape into which a cannabinoid concentrate or the dried leaves or flowers of the plant of the genus cannabis is incorporated,” (1,2). Tetrahydrocannabinol (THC) content has been deemed to be allowable at nothing over 5 mg per serving and 50 mg per package. Currently, patients in the Peace Garden State are only able to obtain botanical cannabis and/or tinctures, topical patches, and capsules.

North Dakota’s medical cannabis access program consists of around 10,000 patients since it’s approval back in 2016 (1).

The bill mentions (2), “1) During a thirty-day period a registered qualifying patient may not purchase or have purchased by a registered designated caregiver more than six ounces [170.01 grams] of dried leaves or flowers of the plant of genus cannabis in a combustible delivery form. (2) At any time a registered qualifying patient, or a registered designated caregiver on behalf of a registered qualifying patient, may not possess more than seven and H. B. NO. 1203 - PAGE 2 one-half ounces [212.62 grams] of dried leaves or flowers of the plant of the genus cannabis in a combustible delivery form. (3) At any time, a registered qualifying patient, or a registered designated caregiver on behalf of a registered qualifying patient, may not possess more than five hundred milligrams of a cannabinoid edible product. c. A registered qualifying patient may not purchase or have purchased by a registered designated caregiver more than the maximum concentration or amount of tetrahydrocannabinol permitted in a thirty-day period. The maximum concentration or amount of tetrahydrocannabinol permitted in a thirty-day period for a cannabinoid concentrate or medical cannabinoid product, or the cumulative total of both, is six thousand milligrams. At any time, a registered qualifying patient, or a registered designated caregiver on behalf of a registered qualifying patient, may not purchase more than three hundred ten milligrams of tetrahydrocannabinol in the form of a cannabinoid edible product.”

With ND HB1203 being signed into law, patients in the state will now be able to use a variety of products with different methods of consumption to help treat their symptoms and health conditions.

References

1. Norml. ND gov signs bill allowing medical cannabis edibles https://norml.org/blog/2025/04/24/north-dakota-governor-signs-legislation-authorizing-patients-to-obtain-cannabis-infused-edible-products/ (accessed Apr 25, 2025).
2. ND - HB1203 https://www.billtrack50.com/billdetail/1774563 (accessed Apr 25, 2025).